Ultrasound-Guided needles: a sharper approach to back pain?

NCT ID NCT07543692

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study will track 600 adults with neck or back pain who are already scheduled to receive pharmacopuncture (herbal medicine injections) as part of their care. The key difference is that doctors will use an ultrasound device to guide the needle, aiming to avoid nerves and blood vessels. Researchers will measure pain levels and safety over 4 weeks to see if this approach improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pharmacopuncture (herbal medicine injection)
What this could lead to
If successful, this could show that using ultrasound guidance makes pharmacopuncture safer and more effective for treating spinal pain.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It only tracks patients for 4 weeks, so long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bucheon Jaseng Hospital of Korean Medicine

    RECRUITING

    Bucheon-si, GGyeonggi-do, 14598, South Korea

  • Daejeon Jaseng Hospital of Korean Medicine

    RECRUITING

    Daejeon, Daejeon, 35262, South Korea

  • Jaseng Hospital of Korean Medicine

    RECRUITING

    Seoul, Gangnam-gu, 06110, South Korea

  • Kyung Hee University Hospital at Gangdong

    RECRUITING

    Seoul, South Korea

  • Kyung Hee University Korean Medicine Hospital

    RECRUITING

    Seoul, 02447, South Korea

  • School of Korean Medicine, Pusan National University

    RECRUITING

    Yangsan, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.